Cornerstone Management, Inc. Bristol Myers Squibb CO Transaction History

Cornerstone Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 09, 2023	SELL	$68.48 - $81.09 $10,272 - $12,163	-150 Reduced 7.73%	1,791 $129 Million
Q1 2022 May 09, 2023	BUY	$61.48 - $73.72 $119,332 - $143,090	1,941 New	1,941 $142 Million
Q3 2017 Jun 01, 2023	SELL	$55.23 - $63.74 $371,863 - $429,161	-6,733 Closed	0 $0
Q2 2017 Jun 01, 2023	SELL	N/A	-1,023 Reduced 13.19%	6,733 $375 Million
Q1 2017 Jun 01, 2023	SELL	N/A	-50 Reduced 0.64%	7,756 $422 Million
Q3 2015 Jun 01, 2023	BUY	N/A	400 Added 5.4%	7,806 $462 Million
Q2 2015 Jun 01, 2023	SELL	N/A	-200 Reduced 2.63%	7,406 $493 Million
Q4 2014 Jun 01, 2023	BUY	N/A	5,815	7,606 $449 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cornerstone Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Cornerstone Management, Inc. with notifications on news.